https://drugdiscoveryscreening....s.com/index.php/larg
Customers were randomly assigned to receive tDCS (letter = 45) or Sertraline (letter = 47). tDCS ended up being administered in 30-min, 2 mA prefrontal stimulation sessions for 10 consecutive weekdays, accompanied by 2 remedies at 4 and 6 days. Sertraline was administered at a dose of 50 mg per day for 6 weeks. The main outcome measure ended up being a modification of the Montgomery-Asberg anxiety Rating Scale (MADRS) score at six months. Mean MADRS ratings d